Applied regulatory science research to evaluate and treat cardiotoxicity of oncology therapeutics

US · MD Food and Drug Administration (HHS-FDA) grant unknown #FOR-FD-25-015

Summary

The Food and Drug Administration (FDA) is forecasting an applied regulatory science research opportunity focused on evaluating and treating cardiotoxicity associated with oncology therapeutics. The work is intended to advance regulatory science by developing methods or tools to assess and potentially mitigate the cardiotoxic effects of cancer treatments. This is a forecasted opportunity, meaning a formal solicitation has not yet been issued. No additional scope details, dollar values, or deadline information are provided in the notice.

What they want

Applied regulatory science research to evaluate and treat cardiotoxicity of oncology therapeutics. The FDA (HHS-FDA) is forecasting research activity under opportunity number FOR-FD-25-015. No further scope details, deliverables, or requirements have been published in this notice.

Risks & flags

Opportunity is only at 'forecasted' stage — no formal solicitation issued yet; scope, eligibility, and evaluation criteria are entirely undefined
Minimal information provided makes it impossible to assess competitive fairness or wiring at this stage

Applied regulatory science research to eva…

$unknown

Onboard ↗